The corporate venturing unit of the Mayo Clinic is among the financiers contributing to the series B round of the China-based healthcare diagnostics company.
China-based healthcare diagnostics company Wuhan Kindstar Diagnostics has secured $11m in series B funding, with backing from the corporate venturing unit of US-based healthcare company the Mayo Clinic as part of a partnership.
Family offiice Morningside Ventures, China-based venture capital (VC) firm the WI Harper Group, and Baird Capital Partners Asia, the Asian division of the US-based private equity group also joined the round.Wuhan had previously raised an undisclosed amount of series A funding, exclusively from Morningside Ventures, in…
